78 related articles for article (PubMed ID: 2508256)
1. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator.
Tranquille N; Emeis JJ
Thromb Haemost; 1989 Jun; 61(3):442-7. PubMed ID: 2508256
[TBL] [Abstract][Full Text] [Related]
2. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region.
Tranquille N; Emeis JJ
Thromb Haemost; 1990 Jun; 63(3):454-8. PubMed ID: 2119527
[TBL] [Abstract][Full Text] [Related]
3. On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region.
Tranquille N; Emeis JJ
Thromb Haemost; 1991 Oct; 66(4):479-83. PubMed ID: 1724576
[TBL] [Abstract][Full Text] [Related]
4. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs.
Smalley DM; Fitzgerald JE; O'Rourke J
Thromb Haemost; 1993 Dec; 70(6):1043-6. PubMed ID: 8165598
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
6. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor.
Tranquille N; Emeis JJ
Thromb Haemost; 1993 Mar; 69(3):259-61. PubMed ID: 8097063
[TBL] [Abstract][Full Text] [Related]
7. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats.
Iacoviello L; D'Adamo MC; De Curtis A; Buczko W; Donati MB
Thromb Haemost; 1995 May; 73(5):841-4. PubMed ID: 7482413
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator release in response to epinephrine in perfused rat hindlegs.
Zhu GJ; Abbadini M; Donati MB; Mussoni L
Am J Physiol; 1989 Feb; 256(2 Pt 2):H404-10. PubMed ID: 2537033
[TBL] [Abstract][Full Text] [Related]
11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
13. Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.
Muldowney JA; Painter CA; Sanders-Bush E; Brown NJ; Vaughan DE
Thromb Haemost; 2007 Feb; 97(2):263-71. PubMed ID: 17264956
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
15. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
16. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
17. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endothelial cell t-PA synthesis and release.
Kooistra T; Schrauwen Y; Arts J; Emeis JJ
Int J Hematol; 1994 Jun; 59(4):233-55. PubMed ID: 8086618
[TBL] [Abstract][Full Text] [Related]
19. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
